healthcare market

Healthcare Market updates includes Medical devices, Pharmaceuticals, Biotechnology, etc

Healthcare Fraud Detection Market Trends Estimates High Demand by 2022

The growth of the market is attributed to a large number of fraudulent activities in healthcare; increasing number of patients seeking health insurance; the prepayment review model; growing pressure of fraud, waste, and abuse on healthcare spending; and high returns on investment.

 

Market Size

The global Healthcare Fraud Detection Market is expected to grow from 2,242.7 million by 2022 from USD 504.4 million in 2016, at a CAGR of 28.9% from 2017 to 2022

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221837663

 

 

“The descriptive analytics segment is expected to dominate the market in 2017”

Based on type, the healthcare fraud detection market is segmented descriptive, predictive, and prescriptive analytics. In 2017, the descriptive analytics segment is expected to account for the largest share of the healthcare fraud detection market. Descriptive analytics forms the base for the effective application of predictive or prescriptive analytics.

 

“The insurance claims review segment is expected to dominate the market in 2017”

Based on application, the healthcare fraud detection market is segmented into insurance claims review, payment integrity, and other applications. The insurance claims review segment is expected to dominate the healthcare fraud detection market with a share in 2017. This segment is also expected to register the highest growth rate during the forecast period, primarily due to the increasing number of patients seeking health insurance, rising number of fraudulent claims, and growing adoption of the prepayment review model.

 

 Recent Developments

  • In 2017, DXC Technology (CSC) entered into a collaboration with Virtual Clarity (UK) to offer clients’ next-generation IT solutions for their cloud environments.
  • In 2016, IBM acquired Truven Health Analytics provider of cloud-based healthcare data, analytics, and insights. This acquisition strengthened IBM’s product portfolio for fraud, waste, and abuse detection and customer base.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=221837663

U.S. Veterinary Infusion Pumps Market Trends Estimates High Demand by 2021

Factors such as the growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels are the primary growth drivers for this market. Growing adoption of companion animals and increasing prevalence of animal diseases requiring surgeries are expected to offer significant growth opportunities to market players in the coming years. However, increasing pet care costs may hinder the growth of this market to a certain extent.

 

Market Size

The global US Veterinary Infusion Pumps Market is estimated to grow at a CAGR of 5.8% from 2016 to 2021, to reach USD 35.4 Million by 2021. 

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160422967

 

“Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market”

Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market and are expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the growing use of these pumps to deliver large volumes of fluids in animals during emergency conditions, provide blood transfusions, and administer total parenteral nutrition at continuous predetermined medium-to-high flow rates.

 

“Private hospitals accounted for the largest share”

In the end-user market, private hospitals accounted for the largest share, majorly due to the increasing use of large-volume infusion pumps and syringe infusion pumps to administer fluids for various clinical conditions in animals, and growth in animal health expenditure.

 

 Recent Developments

  • In August 2015, the company launched the DRE Avanti Plus infusion pump, a volumetric infusion pump that uses a microcontroller for accurate control of infusion rate and volume. 
  • In August 2014, the company established DRE Scientific in the U.S.; the new division is dedicated to selling research-specific equipment packages to universities, laboratories, and other facilities. 

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=160422967

Live Cell Imaging Market Trends Estimates High Demand by 2023

Growth in the live cell imaging market can primarily be attributed to various factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research.

 

Market Size

The global Live Cell Imaging Market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754

 

“By type, the microscopes segment is estimated to hold the largest share of the live cell imaging instruments market”

Based on type, the market is segmented into microscopes, standalone systems, cell analyzers, and accessories. In 2018, the microscopes segment accounted for the largest share of the live cell imaging instruments market. Increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures in order to launch new instruments in the market are the key factors driving the growth of the microscopes market.

 

“By type, the reagents segment is estimated to hold the largest share of the live cell imaging consumables market”

On the basis of type, the global live cell imaging consumables market is segmented into reagents, media, assay kits, and other consumables (microplates, slides, petri dishes, cover slips, and culture chambers). In 2018, the reagents segment accounted for the largest share of the consumables market. The large share of this segment can be attributed to the growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields. 

 

 Recent Developments

  • Leica Microsystems (a subsidiary of Danaher Corporation) entered into an agreement with Triolab AS, a leading distributor of diagnostics and life science products.
  • In September 2018, Leica signed an agreement with Triolab to enable the latter supply and support Leica Microsystems’ confocal, and stereo microscope systems for the life science industry and sample preparation products for electron microscopy.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483

Hearing Aids Market Trends Estimates High Demand by 2022

The growth of this market is majorly attributed to the high prevalence of hearing loss, rising geriatric population, and technological advancements in hearing aids.

 

Market Size

The global Hearing Aids Market is expected to reach USD 9.78 Billion by 2022 from USD 6.56 Billion in 2016, at a CAGR of 7.0% from 2017 to 2022.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198630754

 

“Hearing aid devices segment to dominate the market in 2017”

Based on product, the hearing aids market is segmented into hearing aid devices and hearing implants. In 2017, the hearing aid devices segment is expected to account for the largest share of the hearing aids market. Growth in this segment is majorly driven by the rising geriatric population, technological advancements in hearing devices, and the development and introduction of new and advanced products.

 

“The adult patients segment is projected to register the highest CAGR during the forecast period.”

By patient type, the hearing aid market is segmented into adult patients and pediatric patients. The adult patients segment is estimated to register the highest growth rate during the forecast period. The high growth in this segment can primarily be attributed to the high prevalence of hearing loss in this section of the population.

 

 Recent Developments

  • In February 2017, the Sonova’s  Phonak brand introduced Bolero B-PR and Virto B-Titanium hearing aids, whereas its Unitron brand introduced a new Tempus platform—Moxi Fit R in the market.
  • In April 2017, the William Demant launched Oticon Opn miniRITE hearing aids that feature a rechargeable upgrade option.  

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=198630754

Hysteroscopy Instruments Market Trends Estimates High Demand by 2022

Growth in female geriatric population and rising incidence of gynecological diseases, the increasing adoption of minimally invasive treatments, increasing adoption of office hysteroscopy, and technological advancements are the major factors driving the growth of this market.

 

Market Size

The global Hysteroscopy Instruments Market is expected to reach USD 1.89 Billion by 2022 from USD 1.23 Billion in 2016, growing at a CAGR of 7.8% during the forecast period. 

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219885903

 

“Hysteroscopes expected to dominate the market in 2017”

Based on type, the hysteroscopy instruments market is segmented into handheld instruments, hysteroscopes, resectoscopes, hysterosheaths, fluid management systems, and tissue removal systems. In 2017, the hysteroscopes segment is expected to account for the largest share of the hysteroscopy instruments market. The rising incidence of gynecological diseases and the increasing female geriatric population are the major factors driving the growth of the market.

 

“Based on applications, the diagnostic hysteroscopy segment is projected to grow at the highest CAGR during the forecast period.”

 

By applications, the hysteroscopy instruments market is segmented into diagnostic hysteroscopy and operative hysteroscopy. The diagnostic hysteroscopy segment is expected to grow at the highest rate during the forecast period. The increasing incidence of uterine abnormalities is a major factor driving the demand for diagnostic hysteroscopy.

 

 Recent Developments

  • In 2016, the Olympus opened its Thai - Training and Education Center (T-TEC) in Bangkok (Thailand) that acts as a venue for delivering endoscopy and surgical training and education to medical practitioners in Southeast Asia.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=219885903

Urinalysis Market Trends Estimates High Demand by 2024

Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.

 

Market Size

The global Urinalysis Market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

 

“Pregnancy and fertility tests to dominate the urinalysis market in 2019.”

On the basis of test type, the urinalysis market is segmented into biochemical urinalysis, sediment urinalysis, and pregnancy & fertility tests. In 2019, pregnancy & fertility tests are expected to account for the largest market share. Growing use of these kits in home care settings is driving the growth of this segment.

 

“Hospitals & clinics expected to dominate the urinalysis market in 2019.”

By end user, the urinalysis market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, and research laboratories & institutes. In 2019, hospitals & clinics are expected to account for the largest share of 40% of the market. The large share of this segment can be attributed to factors such as the rapidly growing aging population, the increase in reimbursements for clinical tests performed in hospitals, and the launch of automated urinalysis devices.

 

 Recent Developments

  • In 2018, Beckman Coulter launched IQ Workcell 3000 and 2000.
  • In 2018, DIRUI Industrial Co. Ltd. Launched the FUS 1000 Automated Urine Analyzer.
  • In 2018, Beckman Coulter and Arkray formed a partnership to deliver integrated urine analyzers.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

Reaction Monitoring Market Trends Estimates High Demand by 2022

Factors such as stringent regulatory guidelines in the pharmaceutical & biotechnology industry; expansion of the food and beverages industry; and Increasing public-private investments in life science research are driving the reaction monitoring market.

 

Market Size

The global Reaction Monitoring Market is projected to reach USD 1.52 Billion by 2022 from USD 1.15 Billion in 2017, at a CAGR of 5.7%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52531136

 

“Based on technology, the spectroscopy segment is estimated to account for the largest segment of the market in 2017”

On the basis of technology, the reaction monitoring market is segmented into spectroscopy, chromatography, X-ray diffraction, calorimetry, and titrimetry. The spectroscopy segment is expected to account for largest share of the reaction monitoing market in 2017. The large share of this segment can be attributed to the widespread use of spectroscopic techniques, increasing drug development pipelines, and stringent regulatory compliance for drug manufacturing & food processing protocols.

 

“Based on end user, the pharmaceutical, biopharmaceutical, and biotechnology companies segment expected to account for the largest share of the market in 2017”

Based on end user, the reaction monitoring market is segmented into pharmaceutical, biopharmaceutical, and biotechnology companies, life science and genomic research facilities, food and beverage industry, pollution monitoring and control industry, and other end users. The pharmaceutical, biopharmaceutical, and biotechnology companies segment is estimated to command the largest share of the global reaction monitoring market in 2017.

 

Recent Developments

  • In 2017, Thermo Fisher Scientific signed an agreement with Biognosys AG (Switzerland) to enable library creation and data processing for Data-Independent Acquisition (DIA) studies, through the combined use of Orbitrap mass spectrometers and Spectronaut Pulsar software.
  • In 2016, Waters launched Xevo TQ-XS and a new product line of Differential Scanning Calorimeters.

 For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=52531136

Thawing System Market Trends Estimates High Demand by 2022

Factors driving the growth of this market include technological advanced applications of thawing devices, expanding storage capacities of biorepositories, and increasing use of thawed cells in the treatment of cancers and diabetes.

 

Market Size

The global Thawing System Market is expected to reach USD 252.7 Million by 2022 from USD 124.1 Million in 2016, at a CAGR of 12.6%. 

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185341188

 

“Manual devices are estimated to account for the largest market share in 2017”

On the basis of type, the thawing system market is classified into manual and automated devices. The manual devices segment is expected to lead the global thawing system market in 2017. Factors driving the growth of this segment include low cost and wider availability of manual devices across the globe.

 

“The blood sample segment is estimated to dominate the market in 2017”

By sample type, the market is segmented into blood, embryos, semen, ovum, and other samples (nucleic acids and human tissues). The blood sample segment is anticipated to account for the largest share of the global thawing system market in 2017. Rising incidence of blood disorders and increasing demand for various types of blood products are major factors responsible for the large share of this segment.

 

North America is estimated to command the largest share of the market

Based on region, the thawing system market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the thawing system market in 2017. This is attributed to factors such as improvements in blood bank and biobank infrastructure, increasing research activities in regenerative medicine as well as cell and gene therapy, growing interest in personalized medicine and biomarker discovery, increasing number of biotechnology and pharmaceutical companies, and increasing government funding.

 

 For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=185341188

Cell Counting Market Trends Estimates High Demand by 2023

<!-- wp:paragraph -->

The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.

 

Market Size

The global Cell Counting Market is expected to grow from USD 8.29 billion in 2017 to USD 12.31 billion by 2023, at a CAGR of 6.8% from 2018 to 2023. 

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728

 

“By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018”

On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures. 

 

“By application, the research applications segment is estimated to hold the largest share in 2018”

Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market. 

 

 Recent Developments

  • In 2017, the Danaher Corporation launched two new flow cytometry systems. With a strong portfolio of cell analysis instruments and incessant efforts to develop innovative products, the company is likely to maintain its strong position in this market in the coming years. 
  • The Thermo Fisher has launched its new spectrophotometer units in 2018. The company’s FDA and CE Mark-approved products have helped it to further enhance its presence in this market. 

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728

<!-- /wp:paragraph -->

Medical Ceramics Market Trends Estimates High Demand by 2022

The key factors driving the growth of this market are increasing research activities for the development of novel medical ceramics, growing demand for medical ceramics in plastic surgeries and wound healing applications, rising number of hip and knee replacement procedures, and increasing demand for implantable devices. The growing healthcare industry in emerging economies, increasing research activities in medical ceramics for nanotechnology and electronic devices applications, and increasing number of free trade agreements is an opportunity for the market to grow.

 

Market Size

The global Medical Ceramics Market was valued at USD 12.87 Billion in 2016 and is projected to reach USD 18.45 Billion by 2022, at a CAGR of 6.6%. 

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=237425129

 

“By type of material, the bioinert ceramics segment is expected to account for the largest share of the market in 2017”

On the basis of type of material, the medical ceramics market is broadly segmented into bioinert ceramics, bioactive ceramics, bioresorbable ceramics, and piezoceramics. The bioinert ceramics segment is further divided into zirconia, alumina, and others (titanium, pyrolytic carbon, and silicon nitride). In 2017, the bioinert ceramics segment is expected to account for the largest share and grow at the highest rate during the forecast period.

 

“By application, the dental applications segment is expected to command the largest share of the market in 2017”

On the basis of application, the market is broadly segmented into dental applications, orthopedic applications, cardiovascular applications, surgical instruments, diagnostic instruments, plastic surgery, and other applications (cancer, dialysis, drug delivery systems, and gene therapy). The dental applications segment is expected to command the largest share of the market in 2017.

 

 Recent Developments

  • In March 2013, the CeramTec enhanced its production facilities of the Marktredwitz plant in Germany for advanced ceramics components.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=237425129

Cellular health screening Market Trends Estimates High Demand by 2022

The increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are the major factors that are expected to drive the growth of the cellular health screening market.

 

Market Size

The global Cellular health screening Market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227041930

 

“Single test panels to dominate the market in 2017”

Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. In 2017, the single test panels segment is expected to account for the largest share of the global cellular health screening market. These panels are used to get accurate information about a single biomarker and understand how it affects the health of an individual.

 

“Based on sample collection site, the at-home segment is projected to grow at the highest CAGR”

By sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. The at-home segment is expected to register the highest CAGR during the forecast period.

 

Recent Developments

  • In 2016, the Telomere Diagnostics (US) launched the TeloYears genetic test, which helps track the cellular age of an individual based on the telomere length.
  • The Life Length (Spain) partnered with Eastern Biotech & Life Sciences (Dubai) in 2016 and Freiburg Medical Laboratory Middle East (FML) (Dubai) in 2014 to expand its business in the Middle East. 

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=227041930

Cleanroom Technology Market Trends Estimates High Demand by 2022

Growth in this market is driven majorly by the stringent regulatory framework, growth of the biologics sector, rising demand for sterilized pharmaceutical formulations, growing demand for medical devices, and technological advancements in cleanroom technology.

 

Market Size

The global Cleanroom Technology Market is projected to reach USD 7.9 billion by 2024 from USD 5.7 billion in 2019, at a CAGR of 6.6%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263122482

 

“By product, the consumables segment is expected to account for the largest share of the cleanroom technologies market”

 

The consumables segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the high and growing number of pharmaceutical, biotech, and medical device companies facilitating the use of disposable protective clothing. Also, the large number of R&D activities in the healthcare industry is resulting in a stable demand for cleanroom consumables among end-users. This segment includes safety consumables and cleaning consumables.

 

“In the cleanroom construction market, by type, the hardwall cleanrooms segment is expected to grow at the highest CAGR during the forecast period”

 

The hardwall cleanrooms segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the higher demand for hardwall cleanrooms, as they are more design-flexible than standard and softwall cleanrooms, quick and easy to install, freestanding for easy portability, and easy to expand or reconfigure.

 

Recent Developments

 

  • In July 2019, Azbil Corporation launched its Biological Safety Cabinets, BiOptima.
  • In June 2019, Exyte Group opened a new manufacturing facility in Renningen, Germany.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=263122482

Creatinine Measurement Market Trends Estimates High Demand by 2027

The increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, growing awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rising geriatric population, and increasing number of drug development initiatives are the key drivers for global creatinine measurement market.

 

Market Size

The global Creatinine Measurement Market is expected to reach USD 700.8 million by 2027 from USD 377.2 million in 2018, at a CAGR of 8.4%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385

 

“The Jaffe’s kinetic method segment is expected to hold the largest in the market in 2018”

The creatinine measurement market, by test type, is segmented into the Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is expected to hold the largest share of the creatinine measurement market.

 

“Based on the type of sample, the blood/serum segment is expected to register the highest CAGR during the forecast period”

Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration and low risk of contamination.

 

Recent Developments

  • The F. Hoffmann-La Roche mainly focuses on investments toward R&D activities to fuel innovation. The company invested USD 10.18 billion (19.5% of total sales) on R&D activities in 2017. 
  • The Danaher has a strong focus on research and development and spent USD 1,128.8 million on R&D in 2017. The company has a vast geographic presence in over 60 countries. 

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=206847385

Cerebrospinal Fluid Management Market Trends Estimates High Demand by 2022

The key factors driving the growth of this market include the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population.

 

Market Size

The global Cerebrospinal Fluid Management Market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575

 

 

“By product, the shunts segment held the largest share of the market in 2017”

By product, the cerebrospinal fluid (CSF) management market is segmented into shunts and external drainage systems. In 2017, the shunts segment accounted for the largest share of the global market. The large share of this segment can be primarily attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries owing to shunt malfunction and infection.

 

“By end user, the pediatric segment accounted for the largest share of the market in 2017”

On the basis of end user, the cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. In 2017, the pediatric segment held the largest share of the global market. The large share of this segment can be primarily attributed to high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.

 

Recent Developments

  • Medtronic invested USD 2.2 billion, USD 1.6 billion, and USD 1.5 billion on R&D in 2016, 2015, and 2014, respectively. Medtronic conducts various training programs to support its end users that ensure effective product use and best possible healthcare results.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=160672575

Capnography Equipment Market Trends Estimates High Demand by 2023

Growth in this market is majorly driven by factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of surgeries, and the evolving guidelines related to the clinical use of capnography.

 

Market Size

The global Capnography Equipment Market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3% during the forecast period of 2018 to 2023.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236876330

 

“Accessories to form the largest product segment during the forecast period”

Based on product, the capnography equipment market is categorized into two major segments, namely, capnometers and accessories. The accessories segment is expected to account for a larger market share in 2018. The increasing adoption of capnography equipment during surgical procedures and post-operative monitoring, recommendations by various associations worldwide for the use of capnography equipment during patient monitoring for anesthesia to enhance patient safety, and the growing number of complex and critical surgical procedures worldwide are the major factors driving the growth of the capnography accessories market.

 

“Mainstream capnography segment is estimated to register the highest growth rate in the capnography equipment market, by technology, during the forecast period”

The capnography equipment market, by technology, is segmented into mainstream and sidestream capnography. The mainstream capnography segment is expected to register a higher growth rate during the forecast period owing to factors such as the advantages of mainstream capnography (such as higher accuracy as compared to sidestream capnography), increasing number of surgical procedures, and the increasing adoption of capnography equipment among healthcare professionals.

 

Recent Developments

  • In 2015, the Medtronic (Ireland) opened its regional headquarters in Singapore to improve its market presence in the Asia Pacific region.
  • Smiths Group (UK) invested 6.4% of its total revenue on R&D in 2017. 

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=236876330

Electrophoresis Market Trends Estimates High Demand by 2022

A number of factors, such as the growth in funding for research on electrophoresis techniques, increasing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research are driving the growth of the market. The base year considered for the study is 2016 and the forecast period includes 2017 to 2022.

 

Market Size

The global Electrophoresis Market is projected to reach USD 2.80 Billion by 2022 from USD 2.15 Billion in 2017, at a CAGR of 5.4%.

 

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434

 

“By product, the reagents segment accounted for the largest share of the market in 2016.”

On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. 

 

“By Application, the research segment held the largest market share in 2016.”

Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.

 

Recent Developments

  • In May 2017, the Bio-Rad Laboratories (U.S.) launched its ChemiDoc MP Digital Imaging System—a gel documentation product. The company also focuses on acquiring local and international players providing life science products to expand its business.
  • In 2017, Bio-Rad acquired RainDance Technologies, Inc. (U.S.), a provider of a wide range of life science research and clinical research products that will extend the reach of Bio-Rad into next-generation sequencing (NGS) applications and strengthen its position in the area of Droplet Digital systems.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=434